Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDCARE SYSTEMS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   2.3% 6.0% 2.5% 9.5% 6.6% 3.9% 17.5% 17.5%   Credit score (0-100)   67 40 62 24 35 49 9 9   Credit rating   BBB BBB BBB BB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   664 105 1,288 385 11.6 428 0.0 0.0   EBITDA   243 -440 952 -755 -179 229 0.0 0.0   EBIT   188 -488 857 -887 -264 203 0.0 0.0   Pre-tax profit (PTP)   172.9 -499.6 865.7 -886.8 -338.0 127.0 0.0 0.0   Net earnings   134.4 -390.6 888.7 -906.6 -268.5 103.6 0.0 0.0   Pre-tax profit without non-rec. items   173 -500 866 -887 -338 127 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   76.1 132 243 146 15.4 270 0.0 0.0   Shareholders equity total   1,091 647 1,480 517 191 236 49.9 49.9   Interest-bearing liabilities   384 581 171 620 1,469 1,450 0.0 0.0   Balance sheet total (assets)   2,049 2,019 3,531 2,697 2,207 2,267 49.9 49.9   Net Debt   -58.5 -20.0 -1,318 -472 582 148 -49.9 -49.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   664 105 1,288 385 11.6 428 0.0 0.0   Gross profit growth   23.6% -84.1% 1,121.9% -70.1% -97.0% 3,601.0% -100.0% 0.0%   Employees   2 2 2 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,049 2,019 3,531 2,697 2,207 2,267 50 50   Balance sheet change%   -5.8% -1.5% 74.9% -23.6% -18.2% 2.7% -97.8% 0.0%   Added value   243.0 -439.8 951.6 -755.1 -132.3 228.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -37 7 17 -229 -215 229 -270 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.3% -463.4% 66.6% -230.4% -2,282.9% 47.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.9% -24.0% 31.3% -28.1% -10.8% 9.1% 0.0% 0.0%   ROI %   11.7% -35.9% 59.9% -62.8% -18.9% 12.2% 0.0% 0.0%   ROE %   12.4% -45.0% 83.6% -90.8% -75.8% 48.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   53.3% 32.0% 41.9% 19.2% 8.7% 10.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -24.1% 4.5% -138.5% 62.6% -324.9% 64.5% 0.0% 0.0%   Gearing %   35.2% 89.9% 11.6% 120.0% 767.9% 614.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.9% 2.4% 0.7% 2.9% 7.1% 5.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 0.9 1.2 0.7 0.7 0.8 0.0 0.0   Current Ratio   2.1 1.4 1.6 1.2 1.1 1.0 0.0 0.0   Cash and cash equivalent   442.8 601.4 1,489.3 1,092.7 886.4 1,301.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,015.1 532.8 1,237.1 371.1 175.8 -33.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   121 -220 476 -378 -132 229 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   121 -220 476 -378 -179 229 0 0   EBIT / employee   94 -244 429 -443 -264 203 0 0   Net earnings / employee   67 -195 444 -453 -269 104 0 0